This publication does not independently substantiate FeelGood's performance claims
independent studies have shown that it can suppress VEGFR2 signaling through endocytosis-independent effects
Zepbound (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, when used with a reduced-calorie diet and increased physical activity
As a result, they modulate satiety and reward pathways
Vetenskapliga referenser Husebye, E., Skar, V., Hverstad, T., Iversen, T., & Melby, K
Sections were then blocked and permeabilised using 5% BSA (Sigma Aldrich) and 0.25% triton 100 (Thermo Scientific) for 20 min